Login / Signup

Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8 + T cell-mediated antitumour immunity and improves anti-PD-1 efficacy.

Ning CaiKun ChengYue MaSha LiuRan TaoYani LiDanfeng LiBin GuoWenlong JiaHuifang LiangJianping ZhaoLimin XiaZe-Yang DingJin-Hong ChenWanguang Zhang
Published in: Gut (2023)
HCC.
Keyphrases
  • cancer therapy
  • wild type
  • cell migration
  • drug delivery